335 related articles for article (PubMed ID: 26938947)
41. Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation.
Vogl BA; Fagin U; Nerbas L; Schlenke P; Lamprecht P; Jabs WJ
J Med Virol; 2012 Jan; 84(1):119-31. PubMed ID: 22095540
[TBL] [Abstract][Full Text] [Related]
42. Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV
Hernández DM; Valderrama S; Gualtero S; Hernández C; López M; Herrera MV; Solano J; Fiorentino S; Quijano S
Front Immunol; 2018; 9():2291. PubMed ID: 30337929
[TBL] [Abstract][Full Text] [Related]
43. Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.
Pender MP; Csurhes PA; Smith C; Douglas NL; Neller MA; Matthews KK; Beagley L; Rehan S; Crooks P; Hopkins TJ; Blum S; Green KA; Ioannides ZA; Swayne A; Aftab BT; Hooper KD; Burrows SR; Thompson KM; Coulthard A; Khanna R
JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429369
[TBL] [Abstract][Full Text] [Related]
44. EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation.
McLaughlin LP; Rouce R; Gottschalk S; Torrano V; Carrum G; Wu MF; Hoq F; Grilley B; Marcogliese AM; Hanley PJ; Gee AP; Brenner MK; Rooney CM; Heslop HE; Bollard CM
Blood; 2018 Nov; 132(22):2351-2361. PubMed ID: 30262660
[TBL] [Abstract][Full Text] [Related]
45. The role of virus-specific CD4+ T cells in the control of Epstein-Barr virus infection.
Mautner J; Bornkamm GW
Eur J Cell Biol; 2012 Jan; 91(1):31-5. PubMed ID: 21458882
[TBL] [Abstract][Full Text] [Related]
46. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
47. HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis.
Jilek S; Schluep M; Harari A; Canales M; Lysandropoulos A; Zekeridou A; Pantaleo G; Du Pasquier RA
J Immunol; 2012 May; 188(9):4671-80. PubMed ID: 22461701
[TBL] [Abstract][Full Text] [Related]
48. Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma.
Lin CL; Lo WF; Lee TH; Ren Y; Hwang SL; Cheng YF; Chen CL; Chang YS; Lee SP; Rickinson AB; Tam PK
Cancer Res; 2002 Dec; 62(23):6952-8. PubMed ID: 12460912
[TBL] [Abstract][Full Text] [Related]
49. Signaling by the Epstein-Barr virus LMP1 protein induces potent cytotoxic CD4
Choi IK; Wang Z; Ke Q; Hong M; Qian Y; Zhao X; Liu Y; Kim HJ; Ritz J; Cantor H; Rajewsky K; Wucherpfennig KW; Zhang B
Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E686-E695. PubMed ID: 29311309
[TBL] [Abstract][Full Text] [Related]
50. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
51. Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.
Bollard CM; Gottschalk S; Torrano V; Diouf O; Ku S; Hazrat Y; Carrum G; Ramos C; Fayad L; Shpall EJ; Pro B; Liu H; Wu MF; Lee D; Sheehan AM; Zu Y; Gee AP; Brenner MK; Heslop HE; Rooney CM
J Clin Oncol; 2014 Mar; 32(8):798-808. PubMed ID: 24344220
[TBL] [Abstract][Full Text] [Related]
52. EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients.
Macedo C; Donnenberg A; Popescu I; Reyes J; Abu-Elmagd K; Shapiro R; Zeevi A; Fung JJ; Storkus WJ; Metes D
Transpl Immunol; 2005 Jun; 14(2):109-16. PubMed ID: 15935301
[TBL] [Abstract][Full Text] [Related]
53. Delayed-type hypersensitivity (DTH) immune response related with EBV-DNA in nasopharyngeal carcinoma treated with autologous dendritic cell vaccination after radiotherapy.
Li F; Song D; Lu Y; Zhu H; Chen Z; He X
J Immunother; 2013 Apr; 36(3):208-14. PubMed ID: 23502768
[TBL] [Abstract][Full Text] [Related]
54. Defining the expression hierarchy of latent T-cell epitopes in Epstein-Barr virus infection with TCR-like antibodies.
Sim AC; Too CT; Oo MZ; Lai J; Eio MY; Song Z; Srinivasan N; Tan DA; Pang SW; Gan SU; Lee KO; Loh TK; Chen J; Chan SH; MacAry PA
Sci Rep; 2013 Nov; 3():3232. PubMed ID: 24240815
[TBL] [Abstract][Full Text] [Related]
55. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
[TBL] [Abstract][Full Text] [Related]
56. A11 Tetramer-assisted characterization of Rta-specific CD8+ T-cell responses in healthy virus carriers.
Yu HX; Srinivasan N; Ren EE; Chan SH
Tissue Antigens; 2005 Jun; 65(6):539-43. PubMed ID: 15896201
[TBL] [Abstract][Full Text] [Related]
57. Simultaneous generation of multivirus-specific and regulatory T cells for adoptive immunotherapy.
Lugthart G; Albon SJ; Ricciardelli I; Kester MG; Meij P; Lankester AC; Amrolia PJ
J Immunother; 2012 Jan; 35(1):42-53. PubMed ID: 22130159
[TBL] [Abstract][Full Text] [Related]
58. High incidence of hematologic malignancy relapse after allogeneic transplantation in patients with low Epstein-Barr virus-specific T-cell counts.
Gupta M; Kannappan S; Kalra A; Lam C; Dharmani-Khan P; Williamson T; Tellier R; Daly A; Khan FM; Storek J
Cytotherapy; 2019 Aug; 21(8):886-894. PubMed ID: 31253496
[TBL] [Abstract][Full Text] [Related]
59. Epstein-Barr virus strain heterogeneity impairs human T-cell immunity.
Cirac A; Stützle S; Dieckmeyer M; Adhikary D; Moosmann A; Körber N; Bauer T; Witter K; Delecluse HJ; Behrends U; Mautner J
Cancer Immunol Immunother; 2018 Apr; 67(4):663-674. PubMed ID: 29374782
[TBL] [Abstract][Full Text] [Related]
60. Immunodominant CD8 T cell response to Epstein-Barr virus.
Houssaint E; Saulquin X; Scotet E; Bonneville M
Biomed Pharmacother; 2001 Sep; 55(7):373-80. PubMed ID: 11669500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
